封面
市場調查報告書
商品編碼
2055296

血液檢測市場:依檢測類型、技術、產品、應用、最終用戶、檢體類型和地區分類

Blood Testing Market, By Test Type, By Technology, By Product, By Application, By End User, By Sample Type, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,血液檢測市場規模將達到1,157.6億美元,到2033年將達到2,129.7億美元。預計從2026年到2033年,該市場將以9.1%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 1157.6億美元
歷史數據時期: 2020-2024 預測期: 2026-2033
2026年至2033年預測期間的複合年成長率: 9.10% 2033年市場規模預測: 2129.7億美元

全球血液檢測市場是醫療診斷行業的重要組成部分,涵蓋了廣泛的臨床檢測和診斷程序,這些檢測和程序透過分析血液檢體來進行疾病檢測、健康監測和治療方案製定。血液檢測是循環系統、腫瘤學、感染疾病學、糖尿病管理和常規健康檢查等多個醫學專科的基本診斷工具。該市場包含多種調查方法,從傳統的實驗室檢測到創新的就地檢驗設備、分子診斷以及自動化高性能系統,不一而足。

隨著糖尿病、心血管疾病和癌症等慢性病發病率的不斷上升,以及人們對預防醫學和疾病早期檢測的日益重視,全球對血液檢測服務的需求持續成長。該市場以技術的快速進步為特徵,包括微創檢測技術的開發、人工智慧(AI)應用帶來的檢測精度提升,以及個人化醫療方法的興起。主要市場參與企業包括臨床檢查室、醫院、診斷中心和就地檢驗設備製造商,在全球人口老化、醫療基礎設施改善和健康意識增強的推動下,這些因素共同促進了市場的強勁成長。

市場動態

全球血液檢測市場正受到多個強勁因素的推動,並保持著持續成長的勢頭。其中一個關鍵促進因素是慢性疾病在全球範圍內的日益普遍,包括糖尿病、心血管疾病、癌症和感染疾病。這些疾病需要定期進行血液監測和診斷檢測,以便有效管理病情並最佳化治療方案。此外,全球人口老化也顯著促進了市場擴張,因為老年人需要更頻繁的健康檢查和監測,從而推動了對綜合血液檢測服務的需求成長。技術進步也是一個重要的促進因素,就地檢驗設備、自動化檢測系統、分子診斷和人工智慧診斷工具的創新提高了檢測準確性,加快了結果報告速度,並改善了患者的治療效果。

隨著全球醫療衛生系統將預防性健康管理策略置於優先地位,人們對預防醫學和疾病早期檢測的日益關注正在進一步加速市場成長。然而,市場也存在著許多限制因素。先進診斷設備和檢測程序的高成本可能成為準入障礙,尤其是在醫療預算有限的發展中地區。嚴格的監管要求和漫長的核准流程也帶來了進一步的挑戰,可能導致市場准入延遲和研發成本增加。此外,某些地區熟練的實驗室技術人員和工程師短缺也限制醫療機構的正常運作。

儘管如此,血液檢測在個人化醫療、藥物基因體學和伴隨診斷領域的應用日益廣泛,正透過實現以患者為中心的治療方案,創造著巨大的機會。居家檢測和自我檢測解決方案的普及速度不斷加快,尤其是在新冠疫情對醫療服務模式產生衝擊的情況下,這帶來了盈利的市場機會。亞太、拉丁美洲和非洲等新興市場預計將迎來顯著成長,這主要得益於醫療基礎設施的改善、醫療支出的增加以及人們對定期體檢和診斷檢測重要性的認知不斷提高。

本研究的關鍵特徵

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數介紹了全球血液檢測市場主要參與者的概況:公司亮點、產品系列、關鍵亮點、財務表現和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊可以就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 全球血液檢測市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
  • 相關人員可以透過利用全球血液檢測市場分析中使用的各種策略矩陣,更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 促進因素
  • 抑制因子
  • 機會
  • 影響分析
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景
  • 產業趨勢

第4章 全球血液檢測市場:依檢測類型分類,2021-2033年

  • 臨床化學
  • 血液學和血液凝固檢驗
  • 免疫檢測和血清學
  • 分子血液檢測
  • 微生物學

第5章 全球血液檢測市場:依技術分類,2021-2033年

  • 免疫檢測
  • 聚合酵素鏈鎖反應(PCR)
  • 下一代定序(NGS)
  • 微陣列
  • 臨床化學分析
  • 血液分析儀
  • 質譜分析
  • 流式細胞技術

第6章 全球血液檢測市場:依產品分類,2021-2033年

  • 試劑和試劑盒
  • 儀器和分析設備
  • 耗材(試管、玻片等)
  • 軟體和服務

第7章 全球血液檢測市場:依應用領域分類,2021-2033年

  • 疾病診斷
  • 健康監測
  • 治療監測
  • 產前篩檢
  • 術前檢查
  • 藥物濫用檢測

第8章 全球血液檢測市場:依最終用戶分類,2021-2033年

  • 醫院
  • 診斷實驗室
  • 血庫
  • 研究機構和學術機構
  • 居家照護和自我檢測用戶

第9章 全球血液檢測市場:依檢體類型分類,2021-2033年

  • 全血
  • 血清
  • 電漿

第10章 全球血液檢測市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第11章 競爭格局

  • Abbott Laboratories
  • Hoffmann-La Roche Ltd
  • Siemens Healthineers
  • Thermo Fisher Scientific Inc.
  • Beckman Coulter Inc.(Danaher Corporation)
  • Bio-Rad Laboratories Inc.
  • Becton Dickinson and Company(BD)
  • Ortho Clinical Diagnostics
  • Quest Diagnostics Incorporated
  • PerkinElmer Inc.
  • Grifols SA
  • bioMerieux SA
  • Cepheid(Danaher Corporation)
  • DiaSorin SpA
  • Nova Biomedical

第12章 分析師建議

  • 機會分析
  • 分析師意見
  • 一致的機會地圖

第13章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI8688

Blood Testing Market is estimated to be valued at USD 115.76 Bn in 2026 and is expected to reach USD 212.97 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.1% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 115.76 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 9.10% 2033 Value Projection: USD 212.97 Bn

The global blood testing market represents a critical segment of the healthcare diagnostics industry, encompassing a comprehensive range of laboratory tests and diagnostic procedures that analyze blood samples to detect diseases, monitor health conditions, and guide treatment decisions. Blood testing serves as a fundamental diagnostic tool across various medical specialties, including cardiology, oncology, infectious diseases, diabetes management, and routine health screenings. The market encompasses diverse testing methodologies ranging from traditional laboratory-based assays to innovative point-of-care testing devices, molecular diagnostics, and automated high-throughput systems.

With the increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer, coupled with the growing emphasis on preventive healthcare and early disease detection, the demand for blood testing services continues to expand globally. The market is characterized by rapid technological advancements, including the development of minimally invasive testing procedures, enhanced accuracy through artificial intelligence integration, and the emergence of personalized medicine approaches. Key market participants include clinical laboratories, hospitals, diagnostic centers, and point-of-care testing device manufacturers, all contributing to the market's robust growth trajectory driven by aging populations, healthcare infrastructure development, and increased healthcare awareness worldwide.

Market Dynamics

The global blood testing market is propelled by several compelling drivers that fuel its sustained growth trajectory. The primary driver stems from the escalating prevalence of chronic diseases worldwide, including diabetes, cardiovascular disorders, cancer, and infectious diseases, necessitating regular blood monitoring and diagnostic testing for effective disease management and treatment optimization. The aging global population significantly contributes to market expansion as elderly individuals require frequent health screenings and monitoring, driving demand for comprehensive blood testing services. Technological advancements represent another crucial driver, with innovations in point-of-care testing devices, automated laboratory systems, molecular diagnostics, and AI-powered diagnostic tools enhancing testing accuracy, reducing turnaround times, and improving patient outcomes.

The growing emphasis on preventive healthcare and early disease detection further accelerates market growth, as healthcare systems worldwide prioritize proactive health management strategies. However, the market faces notable restraints including high costs associated with advanced diagnostic equipment and testing procedures, which can limit accessibility, particularly in developing regions with constrained healthcare budgets. Stringent regulatory requirements and lengthy approval processes for new diagnostic tests and devices pose additional challenges, potentially delaying market entry and increasing development costs. The shortage of skilled laboratory professionals and technicians in certain regions creates operational constraints for healthcare facilities.

Nevertheless, significant opportunities emerge from the expanding applications of blood testing in personalized medicine, pharmacogenomics, and companion diagnostics, enabling tailored treatment approaches. The growing adoption of home-based and self-testing solutions presents lucrative opportunities, particularly accelerated by the COVID-19 pandemic's impact on healthcare delivery models. Emerging markets in Asia Pacific, Latin America, and Africa offer substantial growth potential driven by improving healthcare infrastructure, increasing healthcare expenditure, and rising awareness about the importance of regular health screenings and diagnostic testing.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global blood testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Thermo Fisher Scientific Inc., Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Becton Dickinson and Company (BD), Ortho Clinical Diagnostics, Quest Diagnostics Incorporated, PerkinElmer Inc., Grifols S.A., bioMerieux SA, Cepheid (Danaher Corporation), DiaSorin S.p.A., and Nova Biomedical
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global blood testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood testing market

Market Segmentation

  • Test Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Clinical Chemistry
    • Basic/Lipid Metabolic Panels
    • Electrolyte Panel
    • Liver Function Tests
    • Renal Function Tests
    • Thyroid Function Tests
    • Blood Glucose Tests
  • Hematology and Coagulation
    • Complete Blood Count (CBC)
    • Platelet Count and Function Tests
    • Prothrombin Time/International Normalized Ratio
    • Activated Partial Thromboplastin Time (aPTT)
  • Immunoassay and Serology
    • Autoimmune Disease Testing
    • Allergy Testing
    • Cancer Biomarker Tests
    • Hormone Level Testing
  • Molecular Blood Tests
    • Nucleic Acid Testing (NAT) for Infectious Diseases
    • Pharmacogenomics
    • Oncology (Liquid Biopsy)
  • Microbiology
  • Blood Culture Tests
  • Gram Stains
  • Others
  • Technology Insights (Revenue, USD Bn, 2021 - 2033)
  • Immunoassay
  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing (NGS)
  • Microarray
  • Clinical Chemistry Analysis
  • Hematology Analyzers
  • Mass Spectrometry
  • Flow Cytometry
  • Product Insights (Revenue, USD Bn, 2021 - 2033)
  • Reagents and Kits
  • Instruments and Analyzers
  • Consumables (tubes, slides, etc.)
  • Software and Services
  • Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Disease Diagnosis
  • Wellness and Health Monitoring
  • Therapeutic Drug Monitoring
  • Pre-Natal Screening
  • Pre-Operative Testing
  • Drug of Abuse Testing
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Research Institutes and Academia
  • Home Care and Self-Testing Users
  • Sample Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Whole Blood
  • Serum
  • Plasma
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Abbott Laboratories
  • Hoffmann-La Roche Ltd
  • Siemens Healthineers
  • Thermo Fisher Scientific Inc.
  • Beckman Coulter Inc. (Danaher Corporation)
  • Bio-Rad Laboratories Inc.
  • Becton Dickinson and Company (BD)
  • Ortho Clinical Diagnostics
  • Quest Diagnostics Incorporated
  • PerkinElmer Inc.
  • Grifols S.A.
  • bioMerieux SA
  • Cepheid (Danaher Corporation)
  • DiaSorin S.p.A.
  • Nova Biomedical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Blood Testing Market, By Test Type
    • Global Blood Testing Market, By Technology
    • Global Blood Testing Market, By Product
    • Global Blood Testing Market, By Application
    • Global Blood Testing Market, By End User
    • Global Blood Testing Market, By Sample Type
    • Global Blood Testing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Blood Testing Market, By Test Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Clinical Chemistry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Basic/Lipid Metabolic Panels
      • Electrolyte Panel
      • Liver Function Tests
      • Renal Function Tests
      • Thyroid Function Tests
      • Blood Glucose Tests
  • Hematology and Coagulation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Complete Blood Count (CBC)
      • Platelet Count and Function Tests
      • Prothrombin Time/International Normalized Ratio
      • Activated Partial Thromboplastin Time (aPTT)
  • Immunoassay and Serology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Autoimmune Disease Testing
      • Allergy Testing
      • Cancer Biomarker Tests
      • Hormone Level Testing
  • Molecular Blood Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Nucleic Acid Testing (NAT) for Infectious Diseases
      • Pharmacogenomics
      • Oncology (Liquid Biopsy)
  • Microbiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Blood Culture Tests
      • Gram Stains
      • Others

5. Global Blood Testing Market, By Technology, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Immunoassay
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Polymerase Chain Reaction (PCR)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Next-Generation Sequencing (NGS)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Microarray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Clinical Chemistry Analysis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Hematology Analyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Mass Spectrometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Flow Cytometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Blood Testing Market, By Product, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Reagents and Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Instruments and Analyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Consumables (tubes, slides, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Software and Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Blood Testing Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Disease Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Wellness and Health Monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Therapeutic Drug Monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Pre-Natal Screening
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Pre-Operative Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Drug of Abuse Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Blood Testing Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Blood Banks
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Research Institutes and Academia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Home Care and Self-Testing Users
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Blood Testing Market, By Sample Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Whole Blood
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Serum
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Plasma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

10. Global Blood Testing Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Beckman Coulter Inc. (Danaher Corporation)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton Dickinson and Company (BD)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ortho Clinical Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quest Diagnostics Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PerkinElmer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Grifols S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • bioMerieux SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cepheid (Danaher Corporation)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DiaSorin S.p.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nova Biomedical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About Us